{"id":"NCT00595270","sponsor":"Valneva Austria GmbH","briefTitle":"Long Term Persistence and Effect of a Booster Dose of the Japanese Encephalitis Vaccine IC51","officialTitle":"Long Term Persistence and Effect of a Booster Dose of the Japanese Encephalitis Vaccine IC51","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2005-10","primaryCompletion":"2007-09","completion":"2009-04","firstPosted":"2008-01-16","resultsPosted":"2014-03-07","lastUpdate":"2014-03-07"},"enrollment":349,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Japanese Encephalitis"],"interventions":[{"type":"BIOLOGICAL","name":"IC51","otherNames":["Japanese Encephalitis purified inactivated vaccine"]}],"arms":[{"label":"IC51","type":"OTHER"}],"summary":"The study investigates the long term persistence the Japanese encephalitis vaccine IC51 and the need of a booster dose","primaryOutcome":{"measure":"Long Term Immunogenicity of IC51 Vaccine 24 Months After the Primary Vaccination","timeFrame":"- 24 months","effectByArm":[{"arm":"IC51 2 x 6 µg","deltaMin":56,"sd":null},{"arm":"IC51 1 x 12 µg","deltaMin":7,"sd":null},{"arm":"IC51 1 x 6 µg","deltaMin":5,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":3,"exclusionCount":3},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":4,"n":116},"commonTop":["Nasopharyngitis","Headache","Fatique","Influenza Like Ilness","Pharyngolaryngeal Pain"]}}